関連する実験動画
Updated: Sep 9, 2025

06:14
Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
6.8K
腫瘍性ヘルペス シンプレックス ウイルス 療法: 最新 の 進歩, 根本 的 な 課題, 将来 の 見込み
Yiyang Zheng1, Yusheng Pei1, Chunyan Dong1
1State Key Laboratory of Drug Regulatory Sciences, National Institutes for Food and Drug Control, Beijing 102629, China.
Vaccines
|August 28, 2025
まとめ
腫瘍性ヘルペス・シンプレックスウイルス (oHSV) 治療は,遺伝子改変と組み合わせた治療を含む主要な戦略で,がん治療において有望である. 将来の研究は,耐火性がんの有効性を向上させるための精密工学と新しい配送システムに焦点を当てています.
科学分野:
- 腫瘍学
- ウイルス学
- 免疫療法
背景:
- 腫瘍解毒ウイルス (OV) 療法,特に腫瘍解毒ヘルペスシンプレックスウイルス (oHSV) は,新たながん治療戦略である.
- 臨床のマイルストーンには,Talimogene laherparepvec (T- VEC) とTeserpaturev/ G47ΔのFDA承認が含まれています.
研究 の 目的:
- 過去10年のoHSV治療における臨床前と臨床的進歩をまとめます.
- 標的の選択,遺伝子改変,投与,配達における課題を分析する.
- oHSVの新たな感染媒介と遺伝子編集戦略を検証する.
主な方法:
- oHSV治療に関する臨床前および臨床研究の文献レビュー.
- 遺伝子組み換え技術と配送システムの分析
- 免疫調節トランスゲンと免疫チェックポイント阻害剤との組み合わせ戦略の評価
主要な成果:
- 免疫調節性トランスゲン (サイトカイン,抗体) でoHSVを活性化すると,治療効果が向上する.
- 免疫チェックポイント阻害剤とoHSVを組み合わせることは,改善された結果のための重要な戦略です.
- ナノ粒子やメゼンキマ幹細胞 (MSC) のような新しい配送手段は 可能性を示しています
結論:
- 耐火性がんの治療には 有望な戦略です
- CRISPR/Cas9による精密工学と バイオマーカー主導のパーソナライズド医療は 将来の研究方向です
- より安全で効果的なoHSVベースの治療法を開発することが主な目標です.
関連する概念動画
Microorganisms in Medicine and Therapeutics
312
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
312
Subviral Agents
111
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
111
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

